The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation.
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery*; D000293:Adolescent; D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000601:surgery*; D004967:Estrogens / Q000502:physiology / Q000528:radiation effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000502:physiology / Q000528:radiation effects; D006801:Humans; D007044:Hysterectomy; D007986:Luteinizing Hormone / Q000502:physiology / Q000528:radiation effects; D008722:Methods; D010053:Ovary / Q000502:physiology* / Q000528:radiation effects / Q000601:surgery; D011183:Postoperative Complications; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy / Q000601:surgery*
D004967:Estrogens; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone